Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

NCT03407040 · clinicaltrials.gov ↗

TERMINATED

Status

98

Enrollment

NIH

Sponsor class

Stopped Investigator left NIH

Conditions

Gastrointestinal Cancers
Breast Cancer
Pancreatic Cancer
Melanoma
Lung Cancer

Sponsor

National Cancer Institute (NCI)